Inbec – Abacavir (600mg) + Dolutegravir (50mg) + Lamivudine (300mg) | Trusted Global Supplier – GlobMed India 🌍💊
Inbec is a fixed-dose combination antiretroviral medication containing Abacavir 600mg, Dolutegravir 50mg, and Lamivudine 300mg. This triple-drug therapy is widely used for the effective management of HIV-1 infection. It helps control viral replication, strengthen immunity, and improve long-term treatment outcomes.
Uses:
• Treatment of HIV-1 infection
• Reduces viral load in the bloodstream
• Improves CD4 cell count
• Prevents progression to AIDS
• Supports long-term antiretroviral therapy (ART)
Dosage:
• One tablet once daily or as directed by a physician
• Can be taken with or without food
• Take at the same time every day
• Do not skip doses for maximum effectiveness
Treatment Benefits:
• Strong viral suppression
• Improves immune response
• Helps maintain long-term HIV control
• Convenient once-daily regimen
• Reduces risk of drug resistance
Advantages:
✔ Combination of three effective medicines
✔ Better patient compliance
✔ WHO-recommended regimen
✔ Proven safety profile
✔ Suitable for long-term therapy
Storage Condition:
• Store below 25°C
• Keep away from moisture and heat
• Protect from direct sunlight
• Keep out of reach of children
Alternative Indian Brands:
• Viropil – Emcure
• TLD – Mylan/Viatris
• Instgra-AL – Hetero
• Trioday – Cipla
• Abamune-LD – Cipla
GlobMed India – Trusted Medicine Exporter 🚚
GlobMed India supplies genuine pharmaceutical medicines with secure packaging and fast worldwide delivery.
We Export to:
South Korea, Africa, Thailand, Vietnam, Middle East and South East Countries. ✈️📦
Get Fast & Safe Delivery Worldwide 🌐
Website: https://globmedindia.com
Contact Details :
Email Id : info@globmedindia.com
Phone No. : 9730316395
Whatsapp No. : 9730316395
#Inbec #Abacavir #Dolutegravir #Lamivudine #HIVTreatment #ARTTherapy #GlobMedIndia #MedicineExporter #PharmaExport #GlobalDelivery #HIVMedication
 + Dolutegravir (50mg) + Lamivudine (300mg) South Korea, Africa, Thailand, Vietnam, Middle East and South East){kind=link}